CH553209A - Verfahren zur herstellung neuer (alpha)-thiazolyl-(alpha)-alkylmalonsaeureester. - Google Patents

Verfahren zur herstellung neuer (alpha)-thiazolyl-(alpha)-alkylmalonsaeureester.

Info

Publication number
CH553209A
CH553209A CH806371A CH806371A CH553209A CH 553209 A CH553209 A CH 553209A CH 806371 A CH806371 A CH 806371A CH 806371 A CH806371 A CH 806371A CH 553209 A CH553209 A CH 553209A
Authority
CH
Switzerland
Prior art keywords
alpha
thiazolyl
acid esters
preparing new
alkylmalonic acid
Prior art date
Application number
CH806371A
Other languages
English (en)
Original Assignee
Ici Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ici Ltd filed Critical Ici Ltd
Publication of CH553209A publication Critical patent/CH553209A/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/08—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D277/12—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/30—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F1/00—Compounds containing elements of Groups 1 or 11 of the Periodic Table

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
CH806371A 1968-03-22 1969-03-21 Verfahren zur herstellung neuer (alpha)-thiazolyl-(alpha)-alkylmalonsaeureester. CH553209A (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB03989/68A GB1192701A (en) 1968-03-22 1968-03-22 Novel Thiazole Derivatives, the preparation thereof and Compositions containing the same

Publications (1)

Publication Number Publication Date
CH553209A true CH553209A (de) 1974-08-30

Family

ID=10033003

Family Applications (2)

Application Number Title Priority Date Filing Date
CH806371A CH553209A (de) 1968-03-22 1969-03-21 Verfahren zur herstellung neuer (alpha)-thiazolyl-(alpha)-alkylmalonsaeureester.
CH434369A CH513907A (de) 1968-03-22 1969-03-21 Verfahren zur Herstellung neuer Thiazolderivate

Family Applications After (1)

Application Number Title Priority Date Filing Date
CH434369A CH513907A (de) 1968-03-22 1969-03-21 Verfahren zur Herstellung neuer Thiazolderivate

Country Status (15)

Country Link
US (1) US3661920A (de)
AT (1) AT284841B (de)
BE (1) BE730284A (de)
BR (1) BR6807374D0 (de)
CA (1) CA948199A (de)
CH (2) CH553209A (de)
CS (3) CS154267B2 (de)
DE (1) DE1913472A1 (de)
DK (3) DK125251B (de)
ES (1) ES365089A1 (de)
FR (1) FR2004544A1 (de)
GB (1) GB1192701A (de)
IE (1) IE32967B1 (de)
IL (1) IL31679A (de)
NL (1) NL6903963A (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2703542C2 (de) * 1977-01-26 1985-09-26 Schering AG, 1000 Berlin und 4709 Bergkamen Thiazolylzimtsäurenitrile, Insektenbekämpfungsmittel enthaltend diese Verbindungen sowie Verfahren zu ihrer Herstellung
US4153703A (en) * 1977-06-30 1979-05-08 Uniroyal, Inc. Method of controlling insects and acarids with certain aryl-substituted thiazoles
US4197306A (en) * 1977-06-30 1980-04-08 Uniroyal, Inc. Aryl-substituted thiazoles
DE2801794A1 (de) 1978-01-17 1979-07-19 Basf Ag Verfahren zur herstellung von thiazolderivaten und neue thiazole
DE2920183A1 (de) * 1979-05-17 1981-04-30 Schering Ag Berlin Und Bergkamen, 1000 Berlin Thiazolyliden-oxo-propionitrile, insektizide mittel enthaltend diese verbindungen sowie verfahren zu ihrer herstellung
US4346094A (en) * 1980-09-22 1982-08-24 Eli Lilly And Company 3-Aryl-5-isothiazolecarboxylic acids and related compounds used to lower uric acid levels
CA2036192A1 (en) 1990-02-13 1991-08-14 Nicholas Meanwell Heterocyclic carboxylic acids and esters
US5077305A (en) * 1990-02-13 1991-12-31 Bristol-Myers Squibb Co. Thiazole carboxylic acids and esters
DE10331675A1 (de) * 2003-07-14 2005-02-10 Bayer Cropscience Ag Hetarylsubstituierte Pyrazolidindion-Derivate
US9550827B2 (en) * 2007-10-19 2017-01-24 The Regents Of The University Of California Methods for ameliorating and preventing central nervous system inflammation

Also Published As

Publication number Publication date
IL31679A (en) 1972-08-30
CH513907A (de) 1971-10-15
DE1913472A1 (de) 1969-11-06
DK125251B (da) 1973-01-22
CS154266B2 (de) 1974-03-29
CA948199A (en) 1974-05-28
AT284841B (de) 1970-09-25
BR6807374D0 (pt) 1973-02-08
BE730284A (de) 1969-09-22
GB1192701A (en) 1970-05-20
IE32967L (en) 1969-09-22
US3661920A (en) 1972-05-09
CS154268B2 (de) 1974-03-29
IE32967B1 (en) 1974-02-06
DK125326B (da) 1973-02-05
FR2004544A1 (de) 1969-11-28
CS154267B2 (de) 1974-03-29
NL6903963A (de) 1969-09-24
DK122393B (da) 1972-02-28
ES365089A1 (es) 1971-01-01

Similar Documents

Publication Publication Date Title
CH553791A (de) Verfahren zur herstellung neuer chinazolinone.
CH552556A (de) Verfahren zur herstellung neuer substituierter chrysanthemumsaeureester.
NL159389B (nl) Werkwijze ter bereiding van 7beta-acylamido-3-methylcef-3-em-4-carbonzuuresters.
CH537410A (de) Verfahren zur Herstellung neuer Thiazolylessigsäureester
CH523222A (de) Verfahren zur Herstellung neuer Ester
CH532556A (de) Verfahren zur Herstellung neuer Hydrazon-N-dithiocarbonsäureester
CH555854A (de) Verfahren zur herstellung von n-substituierten-6,7-methylen-dioxy-4-chinolon-3-carbonsaeure-estern.
CH546215A (de) Verfahren zur herstellung neuer substituierter hydroxyphenylalkylamine.
AT298489B (de) Verfahren zur Herstellung neuer 7-Nitro-8-hydroxy-chinolinester
AT289776B (de) Verfahren zur Herstellung neuer 1-Carbamoyl-3-aroylpyrrolidine
AT289840B (de) Verfahren zur Herstellung neuer O-Alkyl-O-aryl-thiolphosphorsäureester
CH517103A (de) Verfahren zur Herstellung neuer 5-Aryl-, bzw. Heteroaryl-Benzotetrahydrodiazepin-24-dione
CH509303A (de) Verfahren zur Herstellung neuer Cyclopropancarbonsäureester
CH554314A (de) Verfahren zur herstellung neuer fluorenone.
AT305253B (de) Verfahren zur Herstellung neuer Diphenoxyacetamide
AT286250B (de) Verfahren zur Herstellung von γ-Chloracetessigsäureestern
CH547270A (de) Verfahren zur herstellung neuer 18-methyl-5(alpha)-h-androstane.
CH509274A (de) Verfahren zur Herstellung von N,N-Bis-halogenmethyl-carbaminsäureestern
CH549602A (de) Verfahren zur herstellung von 6-aminopenicillansaeure.
AT310147B (de) Verfahren zur Herstellung neuer m-Benzoylphenylalkansäureester
CH547276A (de) Verfahren zur herstellung neuer 1-thio-(alpha)-lincosaminidderivate.
CH549574A (de) Verfahren zur herstellung neuer substituierter dioxopyrazolidine.
CH513131A (de) Verfahren zur Herstellung neuer Aminobenzocycloalkylnitrile
AT293612B (de) Verfahren zur Herstellung neuer Vaccinen
AT288342B (de) Verfahren zur Herstellung neuer aliphatischer difunktioneller Sulfonsäureester

Legal Events

Date Code Title Description
PL Patent ceased